Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15006482Phase 4Not yet recruiting
Phase 4 trial of meloxicam in esophageal cancer (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoints: Blood gas analysis, Immunoglobulin and 1 more. Planned start Jun 2015; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15006482.